TD Asset Management
CLBT icon

TD Asset Management’s Cellebrite CLBT Stock Holding History

TD Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Sell
76,190
-66,078
-46% -$873K ﹤0.01% 1074
2026
Q1 		$1.96M Sell
142,268
-139,702
-50% -$2.11M ﹤0.01% 969
2025
Q4 		$5.08M Sell
281,970
-42,271
-13% -$759K ﹤0.01% 803
2025
Q3 		$6.01M Buy
324,241
+112,005
+53% +$1.76M ﹤0.01% 757
2025
Q2 		$3.4M Buy
212,236
+105,930
+100% +$1.89M ﹤0.01% 823
2025
Q1 		$2.07M Buy
106,306
+95,777
+910% +$2.02M ﹤0.01% 948
2024
Q4 		$232K Hold
10,529
– – ﹤0.01% 1219
2024
Q3 		$177K Buy
10,529
+397
+4% +$5.89K ﹤0.01% 1371
2024
Q2 		$121K Buy
+10,132
New +$113K ﹤0.01% 1352

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

TD Asset Management's CLBT Position: Q2 2026 in Review

TD Asset Management reduced its Cellebrite (CLBT) stake by 46% in Q2 2026, selling an estimated $873K and leaving 76,190 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1074.

TD Asset Management first reported a position in CLBT in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.01M in Q3 2025. 134 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • TD Asset Management held 76,190 shares of Cellebrite worth $1.11M as of Q2 2026.
  • TD Asset Management sold 66,078 Cellebrite shares in Q2 2026, an estimated $873K.
  • Cellebrite made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #1074 holding.
  • TD Asset Management first reported a position in Cellebrite in Q2 2024 and has held it in 9 quarters since.
  • TD Asset Management's Cellebrite position peaked at $6.01M in Q3 2025.
  • 134 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.